Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways
- Friedrich Miescher Institute for Biomedical Research, Basel (Switzerland)
- Cancer and Infection Research Area, AstraZeneca Pharmaceuticals, Macclesfield (United Kingdom)
- Bayer Schering Pharma AG, Wuppertal (Germany)
Untangling the signaling pathways involved in endothelial cell biology is of central interest for the development of antiangiogenesis based therapies. Here we report that Wnt3a induces the proliferation and migration of HUVECs, but does not affect their survival. Wnt3a-induced proliferation was VEGFR signaling independent, but reduced upon CamKII inhibition. In a search for the downstream mediators of Wnt3a's effects on HUVEC biology, we found that Wnt3a treatment leads to phosphorylation of DVL3 and stabilization of {beta}-catenin. Moreover, under the same conditions we observed an upregulation in c-MYC, TIE-2 and GJA1 mRNA transcripts. Although treatment of HUVECs with Wnt5a induced DVL3 phosphorylation, we did not observe any of the other effects seen upon Wnt3a stimulation. Taken together, our data indicate that Wnt3a induces canonical and non-canonical Wnt signaling in HUVECs, and stimulates their proliferation and migration.
- OSTI ID:
- 22199773
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 386, Issue 3; Other Information: Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir
Wnt5a attenuates Wnt3a-induced alkaline phosphatase expression in dental follicle cells